S Vergo, MJ Craner, R Etzensperger, K Attfield… - Brain, 2011 - Oxford Univ Press ... experimental autoimmune encephalomyelitis. Together these findings suggest that blockade of acid-sensing ion channel 1 has the potential to provide both neuro- and myelo-protective benefits in multiple sclerosis. Key words. ... Cited by 5 - Related articles - All 4 versions
AY Hancharou, LP Titov, IU Ramanava… - Journal of Allergy and …, 2011 - jacionline.org « PreviousNext »The Journal of Allergy and Clinical Immunology Volume 127, Issue 2, Supplement , Page AB228, February 2011. Immunophenotype of Myeloid and Plasmacytoid Dendritic Cells in Patients with Multiple Sclerosis. AY Hancharou: Affiliations. ... Cached - All 2 versions
M Aschwanden, JP Halter, UA Walker… - …, 2011 - Br Soc Rheumatology ... from a related (6) or unrelated (5) donor because of acute lymphoblastic (3) or acute myeloid (2) or chronic myeloid leukaemia (2 ... cGvHD assessment of skin activity, the median body surface areas affected by erythematous rash, tethered and non-tethered sclerosis/fasciitis were ... Related articles - All 4 versions
[HTML] from nih.govG Faraco, L Cavone… - Molecular Medicine, 2011 - ncbi.nlm.nih.gov ... presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Ann NY Acad Sci. 2007;1103:179–91. [PubMed]. 10. Lopez-Diego RS, Weiner HL. Novel therapeutic strategies for multiple sclerosis—a multifaceted ... Cited by 1 - Related articles - All 3 versions
SK Hasan, F Buttari, T Ottone, MT Voso… - Neurology, 2011 - AAN Enterprises ... ATT Armitage trend test CI confidence interval FPRP false-positive report probability MS multiple sclerosis MTZ mitoxantrone NHEJ nonhomologous end-joining OR odds ratio sAML secondary acute myeloid leukemia sAPL secondary acute promyelocytic leukemia SNP single ... Related articles - All 3 versions